These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2116167)

  • 21. Direct microscopic monitoring of initial and dynamic clot lysis using plasmin or rt-PA in an in vitro flow system.
    Bizjak N; Bajd F; Vidmar J; Blinc A; Perme MP; Marder VJ; Novokhatny V; Serša I
    Thromb Res; 2014 May; 133(5):908-13. PubMed ID: 24613694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cleavage of surfactant-incorporating fibrin by different fibrinolytic agents. Kinetics of lysis and rescue of surface activity.
    Günther A; Markart P; Kalinowski M; Ruppert C; Grimminger F; Seeger W
    Am J Respir Cell Mol Biol; 1999 Dec; 21(6):738-45. PubMed ID: 10572071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tissue-type plasminogen activator-mediated activation of plasminogen on the surface of group A, C, and G streptococci.
    Kuusela P; Ullberg M; Saksela O; Kronvall G
    Infect Immun; 1992 Jan; 60(1):196-201. PubMed ID: 1370273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A precise and rapid microtitre plate clot lysis assay: methodology, kinetic modeling and measurement of catalytic constants for plasminogen activation during fibrinolysis.
    Jones AJ; Meunier AM
    Thromb Haemost; 1990 Nov; 64(3):455-63. PubMed ID: 2128976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibrin-specific thrombolytic agents.
    Collen D
    Klin Wochenschr; 1988; 66 Suppl 12():15-23. PubMed ID: 3126344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Euglobulin clot lysis induced by tissue-type plasminogen activator is reduced in subjects with increased levels of lipoprotein (a).
    Aznar J; Estellés A; Bretó M; España F; Alós T
    Thromb Res; 1992 Jun; 66(5):569-82. PubMed ID: 1387993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of plasminogen activators and plasminogen with heparin: effect of ionic strength.
    Rijken DC; de Munk GA; Jie AF
    Thromb Haemost; 1993 Nov; 70(5):867-72. PubMed ID: 8128448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of annexin II tetramer in the activation of plasminogen.
    Kassam G; Choi KS; Ghuman J; Kang HM; Fitzpatrick SL; Zackson T; Zackson S; Toba M; Shinomiya A; Waisman DM
    J Biol Chem; 1998 Feb; 273(8):4790-9. PubMed ID: 9468544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of kinetic parameters of the activation of Glu-plasminogen by tissue plasminogen activator obtained from various sources.
    Takada A; Sugawara Y; Takada Y
    Haemostasis; 1988; 18(2):117-25. PubMed ID: 3137140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism of the stimulatory effect of 6-aminohexanoic acid on plasminogen activation by streptokinase or tissue plasminogen activator: the role of chloride.
    Guinn L; Doctor VM
    Eur J Drug Metab Pharmacokinet; 2003; 28(4):315-20. PubMed ID: 14743974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of bovine serum albumins, modified with a variety of carboxyl group agents, as stimulators of tissue-type plasminogen activator-catalyzed activation of plasminogen.
    Soeda S; Shimeno H; Nagamatsu A
    Chem Pharm Bull (Tokyo); 1989 Mar; 37(3):723-8. PubMed ID: 2502319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tissue-type plasminogen activator.
    Lijnen HR; Collen D
    Ann Biol Clin (Paris); 1987; 45(2):198-201. PubMed ID: 2956911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resistance of porcine blood clots to lysis relates to poor activation of porcine plasminogen by tissue plasminogen activator.
    Flight SM; Masci PP; Lavin MF; Gaffney PJ
    Blood Coagul Fibrinolysis; 2006 Jul; 17(5):417-20. PubMed ID: 16788320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Construction and characterization of a t-PA mutant for use in ATTEMPTS: a drug delivery system for achieving targeted thrombolysis.
    Yang VC; Naik SS; Song H; Dombkowski AA; Crippen G; Liang JF
    J Control Release; 2005 Dec; 110(1):164-76. PubMed ID: 16260060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Standard and low molecular weight heparin have no effect on tissue plasminogen activator induced plasma clot lysis or fibrinogenolysis.
    Weitz JI; Kuint J; Leslie B; Hirsh J
    Thromb Haemost; 1991 May; 65(5):541-4. PubMed ID: 1651568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasminogen binding properties of macrophage inflammatory protein (MIP)-2alpha.
    Arza B; Félez J; Fábregas P; Laroche Y; Collen D; Lijnen HR
    Thromb Haemost; 2000 Jul; 84(1):71-7. PubMed ID: 10928473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ionic modulation of the effects of heparin on plasminogen activation by tissue plasminogen activator: the effects of ionic strength, divalent cations, and chloride.
    Young TN; Edelberg JM; Stack S; Pizzo SV
    Arch Biochem Biophys; 1992 Aug; 296(2):530-8. PubMed ID: 1385938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insight into the profibrinolytic activity of dermatan sulfate: effects on the activation of plasminogen mediated by tissue and urinary plasminogen activators.
    Castañon MM; Gamba C; Kordich LC
    Thromb Res; 2007; 120(5):745-52. PubMed ID: 17270255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular mechanisms of fibrinolysis and their application to fibrin-specific thrombolytic therapy.
    Collen D
    J Cell Biochem; 1987 Feb; 33(2):77-86. PubMed ID: 3553213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endothelial cell-mediated conversion of Glu-plasminogen to Lys-plasminogen. Further evidence for assembly of the fibrinolytic system on the endothelial cell surface.
    Hajjar KA; Nachman RL
    J Clin Invest; 1988 Nov; 82(5):1769-78. PubMed ID: 3141482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.